FIRST LINE CHEMOTHERAPY (FLC) USING IRINOTECAN, 5-FLUOROURACIL (5-FU) AND FOLINIC ACID (FA) (FOLFIRI) COMBINED WITH BEVACIZUMAB IN MEATASTATIC COLORECTAL CANCER (MCRC) Conference Paper uri icon

publication date

  • January 1, 2010